When can antiseizure medications be discontinued in a seizure patient?

• A. After a thorough evaluation; many guidelines suggest at least 2 years seizure-free on medication, with gradual taper supervised by clinician; individualized
• B. After a short trial period with no follow-up
• C. Immediately after a single seizure
• D. Only if the patient relocates to another country

Answer: (B)

Discontinuing antiseizure medications is a decision made only after careful evaluation showing sustained seizure control. In practice, this means the patient has been seizure-free for a substantial period on therapy, and the clinician and patient have weighed the risks and benefits of stopping. Most guidelines support attempting withdrawal after about 1 to 2 years of seizure freedom, with a gradual taper that is closely supervised. The taper allows early detection of any relapse and ensures that if seizures recur, treatment can be restarted promptly.

Many factors influence the safety of stopping medications, including the type of seizure, EEG and imaging results, duration and severity of epilepsy, response to treatment, and individual risk of relapse. The process is individualized rather than automatic, because some patients have a higher chance of remaining seizure-free after withdrawal while others are at greater risk of relapse.

Stopping after a short trial with no follow-up or immediately after a single seizure is not supported by evidence, as relapse risk is higher and there is little information to guide a safe plan. Moving to another country does not change the medical plan or the assessment of relapse risk, so it isn’t a criterion for discontinuation.